Thank you for taking the time to read about the new nasal spray that could help stop COVID-19 that donors just like you have helped fund.

Called INNA-051, it boosts the immune system to fight common colds in the nose and throat before it reaches the lungs.

Now, it’s proved remarkably successful in reducing viral replication of COVID-19 as well.

In April 2022 it enters Phase 2 clinical trials on a global basis. Soon, it could be available to protect the most vulnerable in our community, such as the elderly, people with chronic diseases and people with a suppressed immune system.

This medical advancement shows what can happen when you donate to HMRI.

With your support today you can help our researchers develop new therapies and create a better future for you and your loved ones.

Every donation contributes to better health for the community – and all donations $2 or more are tax deductible.